Lataa...
Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin seeking behavior in rats
Opioid use disorder (OUD) causes the death of nearly 130 Americans daily. It is evident then that new avenues for treatment are needed. To this end, studies have reported that ‘satiety’ agents such as the glucagon-like peptide-1 receptor (GLP-1R) agonist, exendin-4 (Ex-4), decreases responding for a...
Tallennettuna:
| Julkaisussa: | Behav Pharmacol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8119287/ https://ncbi.nlm.nih.gov/pubmed/33229892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FBP.0000000000000609 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|